Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	1210.94	45.00	3.43
Graham Fair Price	41.42	10.66	7.54
PEG	51.79	< 0.005	< 0.005
Price/Book	1.19	0.16	0.16
Price/Cash Flow	-49.98	3.24	6.48
Prices/Earnings	-49.40	0.89	1.75
Price/Sales	-49.70	14.06	27.95
Price/FCF	-49.98	3.24	6.48
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-23.76	0.76	1.00
Operating Margin	2.13	0.40	0.39
ROA	100.00	0.03	0.02
ROE	0.02	0.05	100.00
ROIC	0.05	-0.09	78.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.70	-0.27	154.61
Dividends QOQ	0.71	< 0.005	-100.00
EBIT QOQ	1.69	1.05	-37.75
EPS QOQ	3.00	1.00	-66.67
FCF QOQ	12.51	1.02	-91.82
Revenue QOQ	0.96	1.01	5.84
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	9224.45	100.00
Days Sales Outstanding (DSO)	0.00	19.09	100.00
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.08	0.13	60.18
Quick Ratio	0.00	0.76	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	10.53	10.53	< 0.005
Cash	1.05	1.13	7.61
Capex	0.00	0.00	0.00
Free Cash Flow	0.26	0.52	102.31
Revenue	0.06	0.12	101.19
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	2.73	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.17	11.60	6625.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating